Patent · US Active

SIRPalpha-4-1BBL variant fusion protein and methods of use thereof

US12134638B2 · kind B2 · utility

0Cited by

15References

10Claims

0Family size

Assignee

KAHR Medical Ltd. · IL

Inventors

Iris Pecker · Nesher, IL
Itai BLOCH · Modiin-Maccabim-Reut, IL

Key dates

Filing date	Jul 11, 2019
Grant date	Nov 5, 2024
Priority date	—
Expiry date	Jul 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

SIRPalpha-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a SIRPalpha variant. Also provided are polynucleotides and nucleic acid constructs encoding the SIRPalpha-41BBL fusion protein or the isolated polypeptide, host-cells expressing same and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.